Background. Kawasaki disease(KD) is a medium-vessel vasculitis with a predilection for coronary arteries and is of unknown etiology. KD is responsible for the majority of acquired pediatric cardiovascular disease in the industrialized world, and is associated with development of coronary artery aneurysms in approximately 25% of untreated patients. Epidemiologic, pathologic, and clinical characteristics of KD display notable overlap with common pediatric viral illnesses, leading some to hypothesize that a viral infection is the inciting agent for KD.
Background. Colonization with antibiotic-resistant organisms (AROs), including methicillin-resistant S. aureus (MRSA), places neonatal intensive care unit (NICU) patients at increased risk for infection. Infants are routinely screened for MRSA colonization, but reservoirs for ARO acquisition in the NICU are poorly understood.
Methods. Infants with known MRSA nasal colonization and a control group of infants with negative MRSA screening swabs, and their parents, were enrolled in a prospective cohort study. Weekly swabs were obtained to identify AROs from 4 infant body sites, 3 parental body sites, and 5 high-touch environmental surfaces in the NICU. Culture-based methods were used to identify AROs.
Results. Samples were collected 1-14 times (median 7) from 11 MRSA-colonized infants, 7 control infants, 17 mothers, and 9 fathers. Of MRSA-colonized infants, 9 (82%) were colonized with MRSA in the nares, 6 (55%) in the umbilicus, 8 (73%) in the inguinal folds, and 6 (55%) in the rectum over the study period. Six (55%) MRSAcolonized infants had persistent colonization (i.e., 3 consecutive positive samplings) despite receiving decolonization measures. One (14%) control infant was colonized with MRSA during longitudinal sampling. Sixteen (89%) infants were colonized with ceftriaxone-non-susceptible Gram-negative bacteria. Of 110 Enterobacteriaceae isolates recovered from infants, 22% were non-susceptible to gentamicin, 80% to ceftazidime, 33% to cefepime, 2% to meropenem, and 56% to ceftolozane/tazobactam. Six (33%) infants were colonized with Pseudomonas species and 2 (11%) infants were colonized with Acinetobacterspecies. An ARO was recovered at least once from the environment for 13 (72%) infants and from a parent for 13 (72%) infants. Twelve (67%) infants and an environmental surface, and 11 (61%) infants and a parent, were colonized with the same ARO at some point. An environmental surface was colonized with MRSA for 9 (82%) MRSA-colonized infants compared with 3 (43%) controls (P = 0.14). A parent was colonized with MRSA for 9 (82%) MRSA-colonized infants compared with 1 (14%) control (P = 0.01).
Conclusion. Extranasal body sites, parents, and environmental surfaces serve as potential reservoirs of ARO acquisition and transmission in NICU infants.
Disclosures. Background. Infections with antibiotic-resistant organisms (AROs), i.e., methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and multi-drug-resistant Gram-negative rods (MDR-GNR) among infants hospitalized in the Neonatal Intensive Care Unit (NICU) are associated with mortality and serious morbidities. Implementing appropriate infection control policies may help prevent transmission of AROs. However, the most effective strategies for surveillance of AROs in the NICU are unclear. Prior data collected from infants transferred from outside hospitals to 2 NICUs affiliated with New York-Presbyterian (NYP) Hospital detected low rates of ARO colonization in the first week of life. Thus, in 2013 the strategy of performing surveillance on all transferred infants for AROs was changed to performing targeted surveillance on infants transferred at >7 days of life (DOL). The purpose of this study was to assess this change in surveillance strategy and monitor ARO colonization trends in the NICU.
Methods. Data from all infants transported to the NICUs at NYP from 2007 to 2016 were used. Risk factors for colonization with AROs including demographics and admitting diagnoses were explored using a multivariable binomial mixed model clustered by transferring hospital and controlled for NYP NICU. Trends in ARO colonization over time were assessed using negative binomial regression. Site 1 elected not to adopt the change in surveillance policy, and thus was used as a control.
Results. From 2007 to 2016, 2925 infants were transferred to the NYP NICUs, 1101 at Site 1 and 1824 at Site 2; 2571 (88%) had surveillance for at least 1 ARO. There were 226 positive surveillance cultures in 204 infants (8%): 94 (3.7%) for MRSA, 78 (3%) for VRE and 54 (2%) for MDR-GNR. In the final models, transfer DOL remained a highly significant (OR per day = 1.018, CI 95 1.014, 1.022, P < 0.001) predictor of colonization with any ARO. There was no significant increase in the incidence of transferred infants colonized with AROs over time in either NICU; this remained true in infants who were < 7 days of life at Site 1.
Conclusion. These data continue to support the rationale for our change in surveillance policy. Further studies should evaluate the effect of this strategy on ARO transmission in the general NICU population.
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